Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy

Introduction: Tripterygium glycosides (TGs) have been widely used in China to treat diabetic nephropathy (DN); however, proof of their use is scarce. The present study aimed to evaluate the effectiveness and safety of adding TGs to angiotensin-converting enzyme (ACE) inhibitors or angiotensin recept...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jin-Ying Fang, Yue Yang, Zheng Zhang, Shi-Min Jiang, Tian-Yu Yu, Wen-Ge Li
Format: article
Langue:EN
Publié: KeAi Communications Co., Ltd. 2020
Sujets:
Accès en ligne:https://doaj.org/article/18e853934dea4bfaaee54b50b73a26ee
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!